{"disease":{"id":"chloroquine","name":"chloroquine"},"drugs":{"marketed":[{"drug_id":"fusidic-acid","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"doxycyclin","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Doxycyclin","company_name":"Bulovka Hospital","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"mefloquine","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"quinine","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qualaquin","generic_name":"QUININE","company_name":"Sun Pharm Industries","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Antimalarial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"proguanil","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Malarone","generic_name":"PROGUANIL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":60,"revenue":null,"mechanism":"Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body."},{"drug_id":"artemether","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coartem","generic_name":"ARTEMETHER","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Artemether works by rapidly killing malaria parasites in the blood and liver."},{"drug_id":"mefloquine-hydrochloride","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine-hydrochloride","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"atovaquone","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepron","generic_name":"ATOVAQUONE","company_name":"","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death."},{"drug_id":"doxycycline","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":11,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04363450","title":"Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1700,"lead_sponsor_name":"Louisiana State University Health Sciences Center in New Orleans","has_results":false},{"nct_id":"NCT03316092","title":"Monitoring and Preventing Hydroxychloroquine, Plaquenil, Toxicity.","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Dr. S.S. Michel Clinic","has_results":false},{"nct_id":"NCT04347798","title":"IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT","phase":"","overall_status":"COMPLETED","enrollment_count":773,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT04352946","title":"HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":374,"lead_sponsor_name":"GeoSentinel Foundation","has_results":false},{"nct_id":"NCT04340349","title":"Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":214,"lead_sponsor_name":"Instituto Nacional de Rehabilitacion","has_results":false},{"nct_id":"NCT04363827","title":"Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":155,"lead_sponsor_name":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","has_results":false},{"nct_id":"NCT02648464","title":"Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Helsinki University Central Hospital","has_results":false},{"nct_id":"NCT05451277","title":"At the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their Offspring","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Evelyne Vinet","has_results":false},{"nct_id":"NCT04434144","title":"A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh","phase":"","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar","has_results":false},{"nct_id":"NCT06044805","title":"Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Dinka Dugassa","has_results":false},{"nct_id":"NCT05355415","title":"Adaptive Optics Imaging of Outer Retinal Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":false},{"nct_id":"NCT07409740","title":"Optical Coherence Tomography Angiography Evaluation Of Patients Taking Hydroxychloroquine","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT04010110","title":"Hydroxychloroquine Dosing and Toxicity in Ophthalmology Clinics","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"The Eye Center and The Eye Foundation for Research in Ophthalmology","has_results":false},{"nct_id":"NCT03687905","title":"Proliferative Lupus Nephritis Treatment With Chloroquine and Hydroxychloroquine","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT02942381","title":"A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT05647330","title":"Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":55,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT04652648","title":"Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Bryn Mawr Hospital","has_results":false},{"nct_id":"NCT04376814","title":"Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Baqiyatallah Medical Sciences University","has_results":false},{"nct_id":"NCT04477083","title":"Development and Validation of \"Ready-to-Use\" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Mansoura University","has_results":false},{"nct_id":"NCT04342221","title":"Hydroxychloroquine for COVID-19","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"University Hospital Tuebingen","has_results":false},{"nct_id":"NCT04349228","title":"Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Abderrahmane Mami Hospital","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}